Development of clinical practice assessment guideline of chemotherapy-induced peripheral neuropathy for gynecologic cancer patients
碩士 === 國立成功大學 === 護理學系 === 104 === Standard chemotherapy drugs, including paclitaxel and platinum-based drugs, lead to chemotherapy-induced peripheral neuropathy (CIPN), affecting patients’ sensory or motor peripheral nerves, physical activities, quality of life, and functional status. We aimed to d...
Main Authors: | Ching-LinWu, 吳青琳 |
---|---|
Other Authors: | Yu-Yun Hsu |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/h6dhs5 |
Similar Items
-
Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01) -
Chemotherapy-induced peripheral neuropathy: review for clinical practice
by: Delma Aurélia da Silva Simão, et al. -
Falls Among Hospitalized Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Ching-YiWu, et al.
Published: (2015) -
Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01) -
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
by: Renata Zajączkowska, et al.
Published: (2019-03-01)